apl. Prof. Dr. Luitpold Distel

Einrichtungen, die zum Universitätsklinikum Erlangen gehören Medizinische Fakultät Department of Radiation Oncology

Oncological Patients with systemic Lupus Erythematosus have a clear risk of increased Radiation Sensitivity (2020) Schenker H, Schuster B, Hecht M, Fietkau R, Distel L Conference contribution Effects of Combination Therapy of Kinase Inhibitors and ionizing Radiation on ENT Tumor Cell Lines and Normal Tissue Cells (2020) Faulhaber EM, Scheper J, Jost T, Hecht M, Fietkau R, Distel L Conference contribution Non-professional Phagocytes can phagocytize Necrotic Cells at any Stage of the Cell Cycle (2020) Hofmann A, Seeberg J, Fietkau R, Distel L Conference contribution Influence of neoadjuvant Radiation Therapy on the Quality of Life in Patients with advanced Rectal Cancer over a Period of 5 Years (2020) Sörgel C, Fietkau R, Distel L Conference contribution Comparison of different CDK4/6 Kinase Inhibitors (Palbociclib, Ribociclib, Abemaciclib) and their Influence on the Effectiveness of simultaneous Radiation Therapy (2020) Jost T, Hecht M, Fietkau R, Distel L Conference contribution Accelerated Partial Breast Irradiation: Frequent non-professional Phagocytosis in Patients with early, Hormone Receptor-positive Breast Cancer is associated with good Survival (2020) Bauer M, Schnellhardt S, Rosahl MC, Erber R, Ott O, Fietkau R, Distel L Conference contribution Influence of the ATR and ATM Kinase Inhibitors VE822 and AZD0156 on Melanoma Cell Lines in Combination Therapy with ionizing Radiation (2020) Scheper JSS, Jost T, Faulhaber EM, Hecht M, Fietkau R, Distel L Conference contribution Induction of Senescence in Head and Neck Tumor Cells by Combination of Irradiation and DNA Repair Inhibitors (2020) Dobler C, Jost T, Hecht M, Fietkau R, Distel L Conference contribution PARP inhibitors combined with ionizing radiation induce different effects in melanoma cells and healthy fibroblasts (2020) Weigert V, Jost T, Hecht M, Knippertz I, Heinzerling L, Fietkau R, Distel L Journal article Cytotoxic and immunosuppressive inflammatory cells predict regression and prognosis following neoadjuvant radiochemotherapy of oesophageal adenocarcinoma (2020) Göbel HH, Büttner-Herold M, Fuhrich N, Aigner T, Grabenbauer GG, Distel L Journal article